NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9

AI summary preview · read the full story at The Economic Times

• India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price.
• The cap takes effect from November 9 and applies to all listed drugs, including Atezolizumab and Bevacizumab.